| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/30/2011 | US20110160272 Methods and compositions for use of angiogenesis inhibitors in the prevention and/or control of epilepsy |
| 06/30/2011 | US20110160266 Novel Anti-Arrhythmia Agent |
| 06/30/2011 | US20110160253 Deuterated tizanidine |
| 06/30/2011 | US20110160250 Crystalline forms of a factor xa inhibitor |
| 06/30/2011 | US20110160249 5-lipoxygenase-activating protein inhibitor |
| 06/30/2011 | US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 06/30/2011 | US20110160241 New peptidomimetic compounds |
| 06/30/2011 | US20110160236 Treating Vascular Events with Statins by Inhibiting PAR-1 and PAR-4 |
| 06/30/2011 | US20110160235 Triazolyl tropane derivatives |
| 06/30/2011 | US20110160229 Ahcy hydrolase inhibitors for treatment of hyper homocysteinemia |
| 06/30/2011 | US20110160217 Deuterium enriched analogues of tadalafil as pde5 inhibitors |
| 06/30/2011 | US20110160215 Substituted Triazolo-Pyrazine Compounds |
| 06/30/2011 | US20110160208 Diaryl-substituted five-membered heterocycle derivative |
| 06/30/2011 | US20110160207 Heterocyclic amide compounds useful as kinase inhibitors |
| 06/30/2011 | US20110160205 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 06/30/2011 | US20110160201 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 06/30/2011 | US20110160200 Nitroxyl Progenitors for the Treatment of Pulmonary Hypertension |
| 06/30/2011 | US20110160198 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof |
| 06/30/2011 | US20110160196 Factor xa inhibitors |
| 06/30/2011 | US20110160187 3-aryl-5,6-disubstituted pyridazines |
| 06/30/2011 | US20110160181 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 06/30/2011 | US20110160180 Cannabinoid Receptor Ligands |
| 06/30/2011 | US20110160179 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 06/30/2011 | US20110160174 Method Of Treating Disorder Related To High Cholesterol Concentration |
| 06/30/2011 | US20110160164 Compounds for nonsense suppression and methods for their use |
| 06/30/2011 | US20110160163 INHIBITORS OF p38 |
| 06/30/2011 | US20110160161 Concentrated therapeutic phospholipid compositions |
| 06/30/2011 | US20110160154 Substituted piperazines |
| 06/30/2011 | US20110160153 Methods and Compositions for Treating Blood Circulation Disorders |
| 06/30/2011 | US20110160132 Lymphangiogenesis-promoting agents |
| 06/30/2011 | US20110160121 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 06/30/2011 | US20110160120 Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 06/30/2011 | US20110160119 Anti-inflammatory compounds and uses thereof |
| 06/30/2011 | US20110159169 Drug releasing coatings for medical devices |
| 06/30/2011 | US20110159120 Synergistic anti-inflammatory compositions comprising boswellia serrata extracts |
| 06/30/2011 | US20110159112 Recombinant alpha-fetoprotein and compositions thereof |
| 06/30/2011 | US20110159098 Stabilization and delivery of nucleic acid complexes |
| 06/30/2011 | US20110159094 Extended release compositions for high solubility, high permeability active pharmaceutical ingredients |
| 06/30/2011 | US20110159093 Modified release pharmaceutical compositions |
| 06/30/2011 | US20110159088 ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS |
| 06/30/2011 | US20110159082 Pharmaceutical composition containing fenofibrate and method for the preparation thereof |
| 06/30/2011 | US20110159052 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 06/30/2011 | US20110159015 Human antibodies to human angiopoietin-like protein 4 |
| 06/30/2011 | US20110159009 Anti-vegf antibodies |
| 06/30/2011 | US20110159007 Stable and soluble antibodies inhibiting tnf alpha |
| 06/30/2011 | US20110159006 Use of anti-factor xi antibodies for prevention of thrombus formation |
| 06/30/2011 | US20110159000 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/30/2011 | US20110158999 Antagonists of protease activated receptor-1 (par1) |
| 06/30/2011 | US20110158971 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof |
| 06/30/2011 | US20110158968 Methods of making enhanced, autologous fat grafts |
| 06/30/2011 | US20110158966 Stem cells characterized by expression of germline specific genes |
| 06/30/2011 | US20110158965 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 06/30/2011 | US20110158964 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells |
| 06/30/2011 | US20110158961 Materials and methods relating to cell based therapies |
| 06/30/2011 | US20110158947 Sulfonylurea receptor and means for treating ischaemia |
| 06/30/2011 | US20110158932 Methods And Compositions For The Treatment of Hyperlipidemia |
| 06/30/2011 | US20110158922 Skin Care Compositions and Method of Use Thereof |
| 06/30/2011 | US20110158906 Targeted block copolymer micelles |
| 06/30/2011 | US20110158905 Dock-and-Lock (DNL) Complexes for Therapeutic and Diagnostic Use |
| 06/30/2011 | CA2822747A1 Methods and compositions for cardiovascular diseases and conditions |
| 06/30/2011 | CA2785296A1 Combination composition useful for treating cardiovascular diseases |
| 06/30/2011 | CA2784481A1 Use |
| 06/30/2011 | CA2784180A1 Seven-membered ring compound and pharmaceutical use therefor |
| 06/30/2011 | CA2783704A1 Carboxamide compounds and their use as calpain inhibitors |
| 06/29/2011 | EP2339351A1 Non-peptide agonists and antagonists of adrenomedullin and gastrin releasing peptide |
| 06/29/2011 | EP2339020A1 Diagnostic methods based on Pregnancy-associated plasma protein-A (PAAP-A) |
| 06/29/2011 | EP2339002A1 Fibroblast growth factor homologs |
| 06/29/2011 | EP2338900A1 A method of detecting and/or identifying adeno-associated virus (AAV) sequences and isolating novel sequences identified thereby |
| 06/29/2011 | EP2338899A1 Peptides for activation and inhibition of delta PKC |
| 06/29/2011 | EP2338879A1 New phenylhydrazone derivatives and their use as pharmaceuticals |
| 06/29/2011 | EP2338515A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/29/2011 | EP2338497A1 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 06/29/2011 | EP2338493A1 Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use |
| 06/29/2011 | EP2338490A2 Combinations Useful for the Treatment of Neuronal Disorders |
| 06/29/2011 | EP2337559A2 Method of treating atrial fibrillation |
| 06/29/2011 | EP2039354B1 Compounds blocking the nmda receptor channel and pharmaceutical agent using the same |
| 06/29/2011 | EP1849774B1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME |
| 06/29/2011 | EP1846407B1 7-{4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]phenyl}-3,9-diazabicyclo[3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dimethylbenzyl)amide as inhibitor of renin for the treatment of hypertension. |
| 06/29/2011 | EP1503788B1 Treatment of alpha-galactosidase a deficiency |
| 06/29/2011 | EP1233943B1 Ionizable indolinone derivatives and their use as ptk ligands |
| 06/29/2011 | CN201879280U Vehicle-mounted back pillow adopting traditional Chinese medicine for lowering high blood pressure |
| 06/29/2011 | CN1972932B Compounds for treating dyslipidemia |
| 06/29/2011 | CN1569270B Method for preparing cardiovascular drug eluting stent |
| 06/29/2011 | CN102112495A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112494A Dual variable domain immunoglobulins and uses thereof |
| 06/29/2011 | CN102112451A Diazepan and piperazine derivatives modulators of chemokine receptors |
| 06/29/2011 | CN102112149A Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases |
| 06/29/2011 | CN102112143A Methods and compositions for preventing, reducing, or treating damage caused by ischemia and ischemia-like conditions |
| 06/29/2011 | CN102112134A Composition for prevention or treatment of hyperlipidemia, fatty liver or obesity |
| 06/29/2011 | CN102108372A Preparation method and application of beta-glucan |
| 06/29/2011 | CN102108350A Preparation method of bromelin |
| 06/29/2011 | CN102107006A Coupling medicament for treating diabetes mellitus and medicinal application thereof |
| 06/29/2011 | CN102106999A Chinese medicinal compound preparation for treating dysphagia due to stroke and preparation method thereof |
| 06/29/2011 | CN102106979A Medicament for treating hypertension |
| 06/29/2011 | CN102106974A Oral liquid for healing hemiplegia |
| 06/29/2011 | CN102106970A Crocodile gall wine as well as preparation method and use thereof |
| 06/29/2011 | CN102106958A Chinese medicine for treating hypertension |
| 06/29/2011 | CN102106941A Traditional Chinese medicine preparation for treating piles and preparation method of traditional Chinese medicine preparation |
| 06/29/2011 | CN102106939A Quality control method for extract concentrated liquor of condensed pills of six ingredients with rehmannia root |
| 06/29/2011 | CN102106927A Fat-clearing pressure-reducing tea |